EIDOS THERAPEUTICS, INC. Operating Expenses
EIDOS THERAPEUTICS, INC. reported Operating Expenses of $14.79 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-08-01
- EIDOS THERAPEUTICS, INC. operating expenses for the quarter ending 2019-06-30 was $14.79M, a 82.89% increase year-over-year.
- EIDOS THERAPEUTICS, INC. operating expenses for the quarter ending 2019-03-31 was $12.58M, a 57.36% increase year-over-year.
- EIDOS THERAPEUTICS, INC. operating expenses for the quarter ending 2018-12-31 was $10.71M, a 109.45% increase year-over-year.
- EIDOS THERAPEUTICS, INC. operating expenses for the quarter ending 2018-09-30 was $10.99M, a 296.25% increase year-over-year.
- EIDOS THERAPEUTICS, INC. operating expenses for fiscal 2018 was $37.78M, a 214.41% increase from fiscal 2017.
- EIDOS THERAPEUTICS, INC. operating expenses for fiscal 2017 was $12.02M, a 403.82% increase from fiscal 2016.
- EIDOS THERAPEUTICS, INC. operating expenses for fiscal 2016 was $2.38M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | $14.79M 10-Q · filed 2019-08-01 | $27.38M 10-Q · filed 2019-08-01 | $38.08M derived: sum of 3 quarters · filed 2019-08-01 | $49.07M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2019-03-31 | $12.58M 10-Q · filed 2019-05-07 | $23.29M derived: sum of 2 quarters · filed 2019-05-07 | $34.28M derived: sum of 3 quarters · filed 2019-05-07 | $42.37M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-12-31 | $10.71M derived: 10-K 12 month − 10-K 9 month · filed 2019-04-15 | $21.69M derived: sum of 2 quarters · filed 2019-04-15 | $29.78M derived: sum of 3 quarters · filed 2019-08-01 | $37.78M 10-K · filed 2019-04-15 | |||
| 2018-09-30 | $10.99M 10-K · filed 2019-04-15 | $10.55M 10-Q · filed 2018-11-06 | $19.08M derived: sum of 2 quarters · filed 2019-08-01 | $27.07M 10-K · filed 2019-04-15 | $28.02M 10-Q · filed 2018-11-06 | $32.19M derived: sum of 4 quarters · filed 2019-08-01 | |
| 2018-06-30 | $8.09M 10-Q · filed 2019-08-01 | $9.29M 10-Q · filed 2018-08-07 | $16.09M 10-Q · filed 2019-08-01 | $17.47M 10-Q · filed 2018-08-07 | $21.20M derived: sum of 3 quarters · filed 2019-08-01 | $23.97M derived: sum of 4 quarters · filed 2019-08-01 | |
| 2018-03-31 | $8.00M 10-Q · filed 2019-05-07 | $13.11M derived: sum of 2 quarters · filed 2019-05-07 | $15.88M derived: sum of 3 quarters · filed 2019-05-07 | $17.60M derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | $7.88M derived: sum of 2 quarters · filed 2019-04-15 | $9.60M derived: sum of 3 quarters · filed 2019-04-15 | $12.02M 10-K · filed 2019-04-15 | |||
| 2017-09-30 | $2.77M 10-Q · filed 2018-11-06 | $4.49M derived: sum of 2 quarters · filed 2018-11-06 | $6.91M 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $1.72M 10-Q · filed 2018-08-07 | $4.13M 10-Q · filed 2018-08-07 | |||||
| 2016-12-31 | $2.38M 10-K · filed 2019-04-15 |